Prognostic Factors and Causes of Death in Patients Cured of Esophageal Cancer

Background The number of patients cured of esophageal cancer after esophagectomy is gradually increasing owing to advances in surgical techniques, perioperative management, and adjuvant therapies. This study assessed the clinical course and sought to identify the prognostic factors of these patients...

Full description

Saved in:
Bibliographic Details
Published inAnnals of surgical oncology Vol. 21; no. 5; pp. 1749 - 1755
Main Authors Kakuta, Tomoyuki, Kosugi, Shin-ichi, Kanda, Tatsuo, Ishikawa, Takashi, Hanyu, Takaaki, Suzuki, Tsutomu, Wakai, Toshifumi
Format Journal Article
LanguageEnglish
Published Boston Springer US 01.05.2014
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background The number of patients cured of esophageal cancer after esophagectomy is gradually increasing owing to advances in surgical techniques, perioperative management, and adjuvant therapies. This study assessed the clinical course and sought to identify the prognostic factors of these patients. Methods A series of 220 consecutive patients who underwent esophagectomy and survived for more than 5 years with no relapse were enrolled. Survival analysis was performed using 25 variables including patient characteristics and operative and perioperative factors. Potential prognostic factors were identified by univariate and multivariate analyses, and the development of other primary cancers and the causes of death were retrospectively reviewed. Results The overall 10-, 15-, and 20-year survival rates were 71.6, 50.1, and 32.2 %, respectively, with a median survival time of 180 months (range, 61–315 months). The negative independent prognostic factors identified were age at surgery [hazard ratio (HR), 1.05; P  < .01], being male (HR, 2.62; P  = .02), pulmonary comorbidities (HR, 2.03; P  = .02), synchronous presence of other cancers (HR, 2.35; P  < .01), colonic/jejunal interposition (HR, 1.76; P  = .03), perioperative blood transfusion (HR, 1.92; P  = .02), development of pulmonary complications (HR, 1.71; P  = .02), and adjuvant radiotherapy (HR, 2.13; P  = .01). Pulmonary diseases and other primary cancers were found to be the most common causes of death. Conclusions Careful follow-up including the surveillance of other primary cancers is required for long-term survivors of esophageal cancer after esophagectomy.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1068-9265
1534-4681
DOI:10.1245/s10434-014-3499-7